Therefore, we hypothesize a possible function of reelin in the regulation of the invasiveness of CSCs, specifically from the peritumoral tissue, which can be prospective for the development of new therapeutic approaches for the treatment of GBM patients. This evidence concerns the gene RELN and glioblastoma.